Table 2b Detailed grade 3 and grade 4 clinical toxicities per patient during the trial
Patient no. | Dose (mg m−2) | Type of toxicity | Grade of toxicity | Details | DLT |
|---|---|---|---|---|---|
UPN 7 | 3 | Endocrinian | 3 | Diabetes | Yes |
Infectious | 3 | Candidiasis septicaemia | No | ||
UPN 10 | 5 | Cardiovascular | 3 | Anasarque | Yes |
Digestive | 3 | Haematemesis | Yes | ||
UPN 12 | 5 | Infectious | 3 | Pneumonia | No |
UPN 15 | 5 | Infectious | 4 | Aspergillosis | Yes |
UPN 17 | 5 | Cutaneous | 3 | Rash | Yes |
UPN 19 | 5 | Pain | 3 | Scalp | Yes |
